Tempest Therapeutics Correlations

TPST Stock

USD 0.94 0.03 3.30%

The current 90-days correlation between Tempest Therapeutics and Indaptus Therapeutics is 0.1 (i.e., Average diversification). The correlation of Tempest Therapeutics is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak. If the correlation is 0, the equities are not correlated; they are entirely random.

Tempest Therapeutics Correlation With Market

Weak diversification

The correlation between Tempest Therapeutics and DJI is 0.32 (i.e., Weak diversification) for selected investment horizon. Overlapping area represents the amount of risk that can be diversified away by holding Tempest Therapeutics and DJI in the same portfolio, assuming nothing else is changed.

Check out World Market Map to better understand how to build diversified portfolios, which includes a position in Tempest Therapeutics. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in state.

For more information on how to buy Tempest Stock please use our How to Invest in Tempest Therapeutics guide.

Moving together with Tempest Stock

0.66	MRK	Merck Company Sell-off Trend	Pair Corr
0.66	REGN	Regeneron Pharmaceuticals	Pair Corr

Moving against Tempest Stock

0.57	GNFT	Genfit	Pair Corr
0.56	BMY	Bristol Myers Squibb Aggressive Push	Pair Corr
0.52	GILD	Gilead Sciences	Pair Corr
0.46	CYTHW	Cyclo Therapeutics	Pair Corr
0.35	VRDN	Viridian Therapeutics	Pair Corr
0.51	LPCN	Lipocine	Pair Corr
0.47	PLRX	Pliant Therapeutics	Pair Corr
0.43	RNAC	Cartesian Therapeutics Symbol Change	Pair Corr
0.61	RVMD	Revolution Medicines	Pair Corr
0.6	SYRE	Spyre Therapeutics Symbol Change	Pair Corr
0.59	AKRO	Akero Therapeutics	Pair Corr

Related Correlations Analysis

	INDP	RZLT	CMRA	FBRX	SANA	OLMA	CGEM	LIFE	ZNTL	LYEL
INDP		-0.37	0.64	0.73	0.54	0.41	0.38	0.23	-0.02	0.37	INDP
RZLT	-0.37		-0.42	-0.66	-0.58	-0.25	-0.27	-0.35	-0.06	-0.62	RZLT
CMRA	0.64	-0.42		0.6	0.46	0.07	0.1	0.11	-0.45	0.19	CMRA
FBRX	0.73	-0.66	0.6		0.63	0.55	0.42	0.15	0.15	0.63	FBRX
SANA	0.54	-0.58	0.46	0.63		0.05	0.81	0.26	-0.03	0.62	SANA
OLMA	0.41	-0.25	0.07	0.55	0.05		0.21	-0.11	0.57	0.45	OLMA
CGEM	0.38	-0.27	0.1	0.42	0.81	0.21		0.12	0.23	0.58	CGEM
LIFE	0.23	-0.35	0.11	0.15	0.26	-0.11	0.12		-0.39	-0.01	LIFE
ZNTL	-0.02	-0.06	-0.45	0.15	-0.03	0.57	0.23	-0.39		0.57	ZNTL
LYEL	0.37	-0.62	0.19	0.63	0.62	0.45	0.58	-0.01	0.57		LYEL
	INDP	RZLT	CMRA	FBRX	SANA	OLMA	CGEM	LIFE	ZNTL	LYEL

Click cells to compare fundamentals

Check Volatility

Backtest Portfolio

Please upgrade your account to get full access to Macroaxis premium features

Correlation Matchups

Over a given time period, the two securities move together when the Correlation Coefficient is positive. Conversely, the two assets move in opposite directions when the Correlation Coefficient is negative. Determining your positions' relationship to each other is valuable for analyzing and projecting your portfolio's future expected return and risk.

High positive correlations

CGEM	+ 0.81	SANA
FBRX	+ 0.73	INDP
CMRA	+ 0.64	INDP
SANA	+ 0.63	FBRX
LYEL	+ 0.63	FBRX
LYEL	+ 0.62	SANA

High negative correlations

FBRX	- 0.66	RZLT
LYEL	- 0.62	RZLT
SANA	- 0.58	RZLT
ZNTL	- 0.45	CMRA
CMRA	- 0.42	RZLT
ZNTL	- 0.39	LIFE

Risk-Adjusted Indicators

There is a big difference between Tempest Stock performing well and Tempest Therapeutics Company doing well as a business compared to the competition. There are so many exceptions to the norm that investors cannot definitively determine what's good or bad unless they analyze Tempest Therapeutics' multiple risk-adjusted performance indicators across the competitive landscape. These indicators are quantitative in nature and help investors forecast volatility and risk-adjusted expected returns across various positions.

	Mean Deviation	Jensen Alpha	Sortino Ratio	Treynor Ratio	Semi Deviation	Expected Shortfall	Potential Upside	Value @Risk	Maximum Drawdown
INDP	4.83	(0.57)	0.00	2.27	0.00	0.00	12.60	(11.52)	49.41
RZLT	2.49	0.38	0.12	0.75	2.56	(2.76)	5.54	(4.24)	27.78
CMRA	5.99	0.13	0.00	0.01	0.00	0.00	13.95	(12.70)	30.28
FBRX	3.45	(1.55)	0.00	7.60	0.00	0.00	4.55	(8.94)	24.06
SANA	2.99	(0.52)	0.00	(0.17)	0.00	0.00	5.79	(7.44)	20.66
OLMA	2.47	(0.35)	0.00	(0.12)	0.00	0.00	5.58	(4.84)	12.01
CGEM	2.44	(0.24)	0.00	(0.08)	0.00	0.00	5.88	(5.56)	14.90
LIFE	2.57	0.39	0.11	2.54	2.62	(3.23)	6.45	(5.29)	28.98
ZNTL	4.30	(0.01)	0.03	0.07	4.78	(4.78)	11.41	(7.72)	22.29
LYEL	5.04	(0.28)	0.00	(0.01)	0.00	0.00	13.39	(9.47)	34.35

Tempest Therapeutics Corporate Management

Nicholas Maestas	VP Secretary	Profile
Dr Dubensky	Pres Director	Profile
Justin Trojanowski	Treasurer Controller	Profile
RAC Sakai	Head Quality	Profile
Samuel MD	Executive Officer	Profile
Petpiboon Prasit	Acting Director	Profile
Anne Moon	Project Leadership	Profile

Macroaxis helps investors of all levels and skills to maximize the upside of all their holdings and minimize the risk associated with market volatility, economic swings, and company-specific events. View terms and conditions

Feedback Blog

Made with optimal in San Francisco

2024 Macroaxis LLC